Moderna down after forecasting Q2 revenue below estimates

Moderna

01/05/2026 17:55

Updates

** Shares of vaccine maker Moderna MRNA.O fall 2.7% to $44.7

** Moderna expects Q2 revenue between $50 million and $100 million, below analysts' estimate of $130.6 million - data compiled by LSEG

** Co says Q2 revenue expected to be evenly split between the U.S. and international markets

** Posts Q1 revenue of $389 million, above analysts' estimate of $228 million

** Reports loss of $3.40 per share vs estimated loss of $3.96 per share

** Moderna reiterated its expectation for full-year revenue growth of up to 10% in 2026 from a year ago

** Including session's moves, stock up 52.7% YTD

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))